Safety of Levemir (Insulin Detemir) Treatment in Children and Adolescents With Type 1 Diabetes.
Phase of Trial: Phase IV
Latest Information Update: 30 Oct 2016
At a glance
- Drugs Insulin detemir (Primary)
- Indications Type 1 diabetes mellitus
- Focus Adverse reactions
- Acronyms PREDICTIVE
- Sponsors Novo Nordisk
- 10 Jun 2017 Biomarkers information updated
- 20 Jan 2010 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 30 Sep 2009 Planned end date changed from 1 Jun 2009 to 1 Jun 2010 as reported by ClinicalTrials.gov.